Supply Chain

News

UK takes measures to tackle Utrogestan hormone replacement shortage

Following a year of HRT shortages in 2022, the UK is issuing a serious shortage protocol for Utrogestan amidst new supply issues.

News

EMA issues guidance amidst European medicine shortage

News

Everest and SPH Kyuan partner for XERAVA commercialisation in China

Features

RFID: The future of smart labelling?

Comment

Data is the key to a safer and more controlled pharmaceutical cold-chain

Features

CMO Moves: Regulatory catalysts for drug manufacturing—August

Features

Continuous manufacturing builds on hype but adoption remains gradual

Comment

Supersized Asia and Africa deal to make Merck pill but Covid drug shortage persists

News

US Pharmacopeia report finds high reliance on Indian manufacturers for APIs

Features

A perfect storm: Covid-19 viral vector manufacturing adds further burden to CAR-T development

Features

Two years of Covid-19: lessons the pandemic taught about delivering essential vaccines

Features

Cutting the carbon footprint of pharma’s supply chain

Features

Anaesthesia drugs worst-hit by US drug shortages

Darcy Jimenez and Andrew Hillman

Features

Digitising the pharma supply chain

Features

The dark consequences of drug supply shortages

Features

Global warning: pharma’s role in the climate crisis

News

Valneva could outsource Covid-19 vaccine manufacturing in response to demand

Reynald Castañeda

Features

Covid-19: vaccine pricing varies wildly by country and company

Features

Pharma’s reliance on horseshoe crabs is threatening the species

Features

ICON Q&A: talking affordability in cell and gene therapies

News

Moderna to build $500m vaccine manufacturing facility in Africa

Features

Generic drug safety: US regulators struggle to keep up with a global market

Features

Biologics packaging: unwrapping a complex challenge

Features

Why has the WHO asked governments to delay Covid-19 booster jabs?

Michael Goodier

News

AstraZeneca and EU reach settlement over delayed Covid-19 vaccine doses

Features

Has Covid-19 exposed the weakness of the US pharma supply chain?

Features

Novavax Covid-19 vaccine booster: safety and manufacturing questions remain

Reynald Castañeda

Comment

Human rights considerations imperative for Covid-19 vaccines in developing countries

GlobalData Thematic Intelligence

Features

Blood plasma production: OK for the UK?

Features

Rewriting the pharma supply chain for a post-pandemic world

Features

Donor compensation could improve Europe’s access to plasma therapies

News

J&J agrees to pay $230m to settle opioid case in New York

News

Pfizer and BioNTech to deliver 500 million Covid-19 vaccine doses to the US

Features

Regenerative medicine: ready for the big leagues?

Features

Drug dispensing goes digital

Features

Vaxxinity CEO Mei Mei Hu on vaccine research and democratising health

Features

Covid-19 vaccine inequity: the debate over patent waivers intensifies

News

Pharma supply chain will benefit most from adopting blockchain: Poll